A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens
- 1 May 2016
- journal article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 60 (1s) , 256-261
Abstract
SUMMARY. Since the first report of low pathogenic avian influenza (LPAI) H9N2 virus in Egypt in 2011, the Egyptian poultry industry has suffered from unexpected economic losses as a result of the wide spread of LPAI H9N2. Hence, inactivated H9N2 vaccines have been included in the vaccination programs of different poultry production sectors. The optimal antigen content of avian influenza virus vaccines is essential to reach protective antibody titers. In this study, the correlation between antigen content (based on hemagglutinating units [HAU]) and postvaccination (PV) antibody response of H9N2 inactivated vaccine was studied. Five different vaccine antigen loads (128, 200, 250, 300, and 350 HAU formulas/dose) were investigated in commercial broiler and specific-pathogen-free (SPF) chickens. Vaccine safety and PV antibody responses were monitored. At the fourth week PV only SPF vaccinated groups (128, 200, 250, and 300 HAU/dose) were challenged using LPAI H9N2 (A/Ck/EG/114940v/NLQP/11) virus with 106 EID50... RESUMEN. Estudio de dosis-respuesta en aves libres de patógenos específicos y en pollos de engorde comerciales contra un virus de influenza aviar de baja patogenicidad H9N2 inactivado. Desde el primer informe del virus H9N2 de influenza aviar de baja patogenicidad (LPAI) en Egipto en el año 2011, la industria de las aves avícola de Egipto ha sufrido pérdidas económicas inesperadas como resultado de la amplia propagación del virus de baja patogenicidad H9N2. Por lo tanto, se han incluido vacunas inactivadas H9N2 en los programas de vacunación en los diferentes sectores de la producción avícola. El contenido óptimo de antígeno de las vacunas contra el virus de la influenza aviar es esencial para alcanzar los títulos de anticuerpos protectores. En este estudio, se analizó la correlación entre el contenido de antígeno (basado en unidades hemaglutinantes [HAU]) y la respuesta de anticuerpos después de la vacunación (PV) inducida por la vacuna inactivada H9N2. Se investigaron cinco cargas antigénicas vacunales ...Keywords
This publication has 20 references indexed in Scilit:
- Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in EgyptAvian Pathology, 2014
- Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013Archives of Virology, 2014
- Isolation and mutation trend analysis of influenza A virus subtype H9N2 in EgyptVirology Journal, 2012
- Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in EgyptArchives of Virology, 2012
- Phylogeography and Evolutionary History of Reassortant H9N2 Viruses with Potential Human Health ImplicationsJournal of Virology, 2011
- Animal influenza epidemiologyVaccine, 2008
- An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in KoreaJournal of Veterinary Science, 2008
- Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed GullsJournal of Virology, 2005
- Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virusAvian Pathology, 2004
- The control of H5 or H7 mildly pathogenic avian influenza: A role for inactivated vaccineAvian Pathology, 2002